Investigating the Impact of Gadolinium-Based Contrast Agents on the Corrected QT Interval

Introduction The manufacturing labels for all currently marketed gadolinium-based MRI contrast agents describe adverse cardiac events reported during post-market use. The goal of this study was to determine prolongation of the rate-corrected QT interval occurs in the immediate setting after gadolini...

Descripción completa

Detalles Bibliográficos
Autores principales: Gress, Kyle L, Gallo, Tyler, Urits, Ivan, Geng, Xue, Viswanath, Omar, Kaye, Alan D, Woosley, Raymond L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7485915/
https://www.ncbi.nlm.nih.gov/pubmed/32923263
http://dx.doi.org/10.7759/cureus.9668

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7485915/
https://www.ncbi.nlm.nih.gov/pubmed/32923263
http://dx.doi.org/10.7759/cureus.9668

Ejemplares similares